Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Eicosanoid pathway on host resistance and inflammation during Mycobacterium tuberculosis infection is comprised by LTB4 reduction but not PGE2 increment.

Sorgi CA, Soares EM, Rosada RS, Bitencourt CS, Zoccal KF, Pereira PAT, Fontanari C, Brandão I, Masson AP, Ramos SG, Silva CL, Frantz FG, Faccioli LH.

Biochim Biophys Acta Mol Basis Dis. 2019 Oct 28:165574. doi: 10.1016/j.bbadis.2019.165574. [Epub ahead of print]

PMID:
31666208
2.

Presumed atypical peripapillary Vogt-Koyanagi-Harada disease.

Abucham-Neto JZ, Masson AP, Nascimento PA, Barbosa Ferraz AA, Cunha de Souza E.

Am J Ophthalmol Case Rep. 2019 Aug 27;16:100548. doi: 10.1016/j.ajoc.2019.100548. eCollection 2019 Dec.

3.

A proteomics outlook towards the elucidation of epithelial-mesenchymal transition molecular events.

Silvestrini VC, Lanfredi GP, Masson AP, Poersch A, Ferreira GA, Thomé CH, Faça VM.

Mol Omics. 2019 Oct 7;15(5):316-330. doi: 10.1039/c9mo00095j. Review.

PMID:
31429845
4.

pVAXhsp65 Vaccination Primes for High IL-10 Production and Decreases Experimental Encephalomyelitis Severity.

Zorzella-Pezavento SF, Chiuso-Minicucci F, França TG, Ishikawa LL, da Rosa LC, Colavite PM, Balbino B, Marques C, Ikoma MR, Masson AP, Silva CL, Sartori A.

J Immunol Res. 2017;2017:6257958. doi: 10.1155/2017/6257958. Epub 2017 Feb 21.

5.

Synergy of chemotherapy and immunotherapy revealed by a genome-scale analysis of murine tuberculosis.

Rodrigues RF, Zárate-Bladés CR, Rios WM, Soares LS, Souza PR, Brandão IT, Masson AP, Arnoldi FG, Ramos SG, Letourneur F, Jacques S, Cagnard N, Chiocchia G, Silva CL.

J Antimicrob Chemother. 2015;70(6):1774-83. doi: 10.1093/jac/dkv023. Epub 2015 Feb 16.

PMID:
25687643
6.

Combined immunization using DNA-Sm14 and DNA-Hsp65 increases CD8+ memory T cells, reduces chronic pathology and decreases egg viability during Schistosoma mansoni infection.

Espíndola MS, Frantz FG, Soares LS, Masson AP, Tefé-Silva C, Bitencourt CS, Oliveira SC, Rodrigues V, Ramos SG, Silva CL, Faccioli LH.

BMC Infect Dis. 2014 May 16;14:263. doi: 10.1186/1471-2334-14-263.

7.

Immunotherapy of tuberculosis with Mycobacterium leprae Hsp65 as a DNA vaccine triggers cross-reactive antibodies against mammalian Hsp60 but not pathological autoimmunity.

Doimo NT, Zárate-Bladés CR, Rodrigues RF, Tefé-Silva C, Trotte MN, Souza PR, Soares LS, Rios WM, Floriano EM, Brandão IT, Masson AP, Coelho V, Ramos SG, Silva CL.

Hum Vaccin Immunother. 2014;10(5):1238-43. doi: 10.4161/hv.28249. Epub 2014 Mar 7.

8.

BCG and BCG/DNAhsp65 vaccinations promote protective effects without deleterious consequences for experimental autoimmune encephalomyelitis.

Zorzella-Pezavento SF, Guerino CP, Chiuso-Minicucci F, França TG, Ishikawa LL, Masson AP, Silva CL, Sartori A.

Clin Dev Immunol. 2013;2013:721383. doi: 10.1155/2013/721383. Epub 2013 Oct 29.

9.

A single dose of a DNA vaccine encoding apa coencapsulated with 6,6'-trehalose dimycolate in microspheres confers long-term protection against tuberculosis in Mycobacterium bovis BCG-primed mice.

Carlétti D, Morais da Fonseca D, Gembre AF, Masson AP, Weijenborg Campos L, Leite LC, Rodrigues Pires A, Lannes-Vieira J, Lopes Silva C, Bonato VL, Horn C.

Clin Vaccine Immunol. 2013 Aug;20(8):1162-9. doi: 10.1128/CVI.00148-13. Epub 2013 Jun 5.

10.

Evaluation of the overall IFN-γ and IL-17 pro-inflammatory responses after DNA therapy of tuberculosis.

Zárate-Bladés CR, Rodrigues RF, Souza PR, Rios WM, Soares LS, Rosada RS, Brandão IT, Masson AP, Floriano EM, Ramos SG, Silva CL.

Hum Vaccin Immunother. 2013 May;9(5):1093-103. doi: 10.4161/hv.23417. Epub 2013 Jan 16.

11.

A subunit vaccine based on biodegradable microspheres carrying rHsp65 protein and KLK protects BALB/c mice against tuberculosis infection.

dos Santos SA, Zárate-Bladés CR, de Sá Galetti FC, Brandão IT, Masson AP, Soares EG, Araújo AP, Silva CL.

Hum Vaccin. 2010 Dec;6(12):1047-53. Epub 2010 Dec 1.

PMID:
21157178
12.

Neonatal BCG immunization followed by DNAhsp65 boosters: highly immunogenic but not protective against tuberculosis - a paradoxical effect of the vector?

Pelizon AC, Martins DR, Zorzella-Pezavento SF, Seger J, Justulin LA Jr, da Fonseca DM, Santos RR Jr, Masson AP, Silva CL, Sartori A.

Scand J Immunol. 2010 Feb;71(2):63-9. doi: 10.1111/j.1365-3083.2009.02352.x.

13.

Protective efficacy of different strategies employing Mycobacterium leprae heat-shock protein 65 against tuberculosis.

Souza PR, Zárate-Bladés CR, Hori JI, Ramos SG, Lima DS, Schneider T, Rosada RS, Torre LG, Santana MH, Brandão IT, Masson AP, Coelho-Castelo AA, Bonato VL, Galetti FC, Gonçalves ED, Botte DA, Machado JB, Silva CL.

Expert Opin Biol Ther. 2008 Sep;8(9):1255-64. doi: 10.1517/14712598.8.9.1255 .

PMID:
18694348
14.

Protection against tuberculosis by a single intranasal administration of DNA-hsp65 vaccine complexed with cationic liposomes.

Rosada RS, de la Torre LG, Frantz FG, Trombone AP, Zárate-Bladés CR, Fonseca DM, Souza PR, Brandão IT, Masson AP, Soares EG, Ramos SG, Faccioli LH, Silva CL, Santana MH, Coelho-Castelo AA.

BMC Immunol. 2008 Jul 22;9:38. doi: 10.1186/1471-2172-9-38.

Supplemental Content

Loading ...
Support Center